Binding of 3H-lisuride hydrogen maleate to striatal membranes of rat brain. 1979

N Fujita, and K Saito, and N Yonehara, and Y Watanabe, and H Yoshida

UI MeSH Term Description Entries
D008090 Lisuride An ergot derivative that acts as an agonist at dopamine D2 receptors (DOPAMINE AGONISTS). It may also act as an antagonist at dopamine D1 receptors, and as an agonist at some serotonin receptors (SEROTONIN RECEPTOR AGONISTS). Lysuride Hydrogen Maleate,Methylergol Carbamide,Arolac,Cuvalit,Dopergin,Dopergine,Lisuride Hydrochloride,Lisuride Maleate,Lisuride Maleate (1:1),Lisuride Maleate, (8beta)-Isomer,Lisuride Mesylate,Lisuride Phosphate (1:1),Lisuride, (8alpha)-(+-)-Isomer,Lysenyl,Lysurid,Revanil,Carbamide, Methylergol,Hydrochloride, Lisuride,Hydrogen Maleate, Lysuride,Maleate, Lisuride,Mesylate, Lisuride
D008297 Male Males
D008566 Membranes Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures. Membrane Tissue,Membrane,Membrane Tissues,Tissue, Membrane,Tissues, Membrane
D008784 Methysergide An ergot derivative that is a congener of LYSERGIC ACID DIETHYLAMIDE. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome. Dimethylergometrin,Methylmethylergonovine,Deseril,Desril,Désernil-Sandoz,Methysergide Dimaleate,Methysergide Maleate,Sansert,UML-491,Dimaleate, Methysergide,Désernil Sandoz,Maleate, Methysergide,UML 491,UML491
D010646 Phentolamine A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease. Fentolamin,Phentolamine Mesilate,Phentolamine Mesylate,Phentolamine Methanesulfonate,Phentolamine Mono-hydrochloride,Regitine,Regityn,Rogitine,Z-Max,Mesilate, Phentolamine,Mesylate, Phentolamine,Methanesulfonate, Phentolamine,Mono-hydrochloride, Phentolamine,Phentolamine Mono hydrochloride
D002069 Butaclamol A benzocycloheptapyridoisoquinolinol that has been used as an antipsychotic, especially in schizophrenia. AY-23,028,Butaclamol Hydrochloride,AY 23,028,AY23,028,Hydrochloride, Butaclamol
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004873 Ergolines A series of structurally-related alkaloids that contain the ergoline backbone structure. Ergoline

Related Publications

N Fujita, and K Saito, and N Yonehara, and Y Watanabe, and H Yoshida
January 1991, The Journal of international medical research,
N Fujita, and K Saito, and N Yonehara, and Y Watanabe, and H Yoshida
April 1982, Biochemical pharmacology,
N Fujita, and K Saito, and N Yonehara, and Y Watanabe, and H Yoshida
January 1992, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
N Fujita, and K Saito, and N Yonehara, and Y Watanabe, and H Yoshida
March 1985, The Journal of pharmacy and pharmacology,
N Fujita, and K Saito, and N Yonehara, and Y Watanabe, and H Yoshida
January 1981, Neuroscience,
N Fujita, and K Saito, and N Yonehara, and Y Watanabe, and H Yoshida
January 1990, Psychopharmacology,
N Fujita, and K Saito, and N Yonehara, and Y Watanabe, and H Yoshida
August 1978, Life sciences,
N Fujita, and K Saito, and N Yonehara, and Y Watanabe, and H Yoshida
December 1984, European journal of pharmacology,
N Fujita, and K Saito, and N Yonehara, and Y Watanabe, and H Yoshida
August 1984, Proceedings of the National Academy of Sciences of the United States of America,
N Fujita, and K Saito, and N Yonehara, and Y Watanabe, and H Yoshida
November 1984, Molecular pharmacology,
Copied contents to your clipboard!